Status:
UNKNOWN
Quality of Life Improvements With Cord Blood Plasma
Lead Sponsor:
Hexagon Therapies, LLC
Conditions:
Aging
Eligibility:
All Genders
50-80 years
Phase:
PHASE1
Brief Summary
This study aims to look at whether human umbilical cord blood plasma (HUCBP) is safe for intravascular (iv) administration; and whether it provides any reversal of frailty or other age-related biologi...
Detailed Description
Participants that take part in this experimental treatment will receive six HUCBP infusions over a six month period, with a final check-up occuring six months after the last infusion. Blood samples wi...
Eligibility Criteria
Inclusion
- Aged 50 or older
- Be willing and able to participate during the 12 month research period
- Women - must be diagnosed with infertility or menopause
Exclusion
- Unable to perform tasks required for analysis of end points
- History of being hospitalized dues to infectious disease, such as pneumonia, within the last year
- Recent and current use of immunosuppressive drugs or HIV patients
- Scheduled to receive organ transplant
- Dementia or clinically relevant cognitive impairment
- Participants of previous (within 1 month) or current clinical trials
- Severe heart and kidney failure
- History of alcohol or drug abuse
- Known or suspected pregnancy
- Chronic Hepatitis B or C
- Diagnosis of cancer within 5 year of the study, or the possibility to contract cancer
- Anticancer chemotherapy and radiation therapy
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03229785
Start Date
April 1 2018
End Date
August 1 2019
Last Update
January 24 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.